Charles Allan Email

CEO . MY01.io

Current Roles

Employees:
45
Revenue:
$5M
About
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (ACS); a limb-threatening muscle condition which occurs within 48 hours following a trauma. Currently ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P's), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem. Engineered by NXTSENS
MY01.io Address
400 Boul de Maisonneuve Ouest
Montreal, QC
CAN
MY01.io Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.